Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06419231 · ClinicalTrials.gov registry record · NA
Effectiveness of a Butyrate Formulation and Butyrate + Polyphenol Formulation on Gut Health, Permeability and Associated Symptoms
A NA study, sponsored by Supplement Formulators.
- Completed
- Registry status
- NA
- Development phase
- 143
- Enrollment target
NCT06419231 is a NA study that has completed, run by Supplement Formulators. The registered enrollment target is 143 participants.
The verdict
NCT06419231, a NA study, has completed, sponsored by Supplement Formulators.
- COMPLETED
- Registry status
- NA
- Development phase
- 143 participants
- Enrollment target
Study Summary
The purpose of this study is the assess the effectiveness and safety of a Butyrate formulation and a Butyrate + Polyphenol formulation on gut health, permeability and associated symptoms
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Butyrate + Polyphenol Formulation
- DIETARY_SUPPLEMENT Butyrate Formulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 143 participants |
| Start Date | 2023-10-31 |
| Est. Completion | 2025-06-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06419231
The ClinicalTrials.gov registry entry for NCT06419231 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 143 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Supplement Formulators, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT06419231 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06419231 about?
NCT06419231 is a clinical study titled "Effectiveness of a Butyrate Formulation and Butyrate + Polyphenol Formulation on Gut Health, Permeability and Associated Symptoms". The purpose of this study is the assess the effectiveness and safety of a Butyrate formulation and a Butyrate + Polyphenol formulation on gut health, permeability and associated symptoms
What is the current status of trial NCT06419231?
This trial is currently completed. It is a NA study. The enrollment target is 143 participants. The study started on 2023-10-31. Estimated completion is 2025-06-18.
What interventions are being tested in trial NCT06419231?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Butyrate + Polyphenol Formulation (DIETARY_SUPPLEMENT), Butyrate Formulation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06419231?
This trial is sponsored by Supplement Formulators, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.